{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:23:04Z","timestamp":1788402184539,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The human immunodeficiency virus epidemic continues in sub-Saharan Africa, and particularly affects adolescent girls and women who have limited access to antiretroviral therapy. Here we report that the risk of vaginal simian immunodeficiency virus (SIV)<jats:sub>mac251<\/jats:sub> acquisition is reduced by more than 90% using a combination of a vaccine comprising V1-deleted (V2 enhanced) SIV envelope immunogens with topical treatment of the zinc-finger inhibitor SAMT-247. Following 14 weekly intravaginal exposures to the highly pathogenic SIV<jats:sub>mac251<\/jats:sub>, 80% of a cohort of 20 macaques vaccinated and treated with SAMT-247 remained uninfected. In an arm of 18 vaccinated-only animals without microbicide, 40% of macaques remained uninfected. The combined SAMT-247\/vaccine regimen was significantly more effective than vaccination alone. By analysing immune correlates of protection, we show that, by increasing zinc availability, SAMT-247 increases natural killer cytotoxicity and monocyte efferocytosis, and decreases T-cell activation to augment vaccine-induced protection.<\/jats:p>","DOI":"10.1038\/s41564-023-01353-7","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T16:02:59Z","timestamp":1680796979000},"page":"905-918","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Vaccine plus microbicide effective in preventing vaginal SIV transmission in macaques"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6120-8943","authenticated-orcid":false,"given":"Mohammad Arif","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3455-3992","authenticated-orcid":false,"given":"Massimiliano","family":"Bissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Silva de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Helmold Hait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Stamos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzana","family":"Bhuyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Hunegnaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarkis","family":"Sarkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-6432","authenticated-orcid":false,"given":"Anna","family":"Gutowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin N.","family":"Doster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Moles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1245-1338","authenticated-orcid":false,"given":"Lisa M.","family":"Miller Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0569-9722","authenticated-orcid":false,"given":"Ettore","family":"Appella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8990-158X","authenticated-orcid":false,"given":"David J.","family":"Venzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoyoung","family":"Choo-Wosoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0643-4497","authenticated-orcid":false,"given":"Timothy","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-5649","authenticated-orcid":false,"given":"Marc M.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Appella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Robert-Guroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2851-6589","authenticated-orcid":false,"given":"Genoveffa","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"key":"1353_CR1","unstructured":"UNAIDS. FACT SHEET \u2013 WORLD AIDS DAY 2021 Vol. 2022 (UNAIDS, 2021)."},{"key":"1353_CR2","doi-asserted-by":"publisher","first-page":"e1521","DOI":"10.1016\/S2214-109X(19)30410-3","volume":"7","author":"I Birdthistle","year":"2019","unstructured":"Birdthistle, I. et al. Recent levels and trends in HIV incidence rates among adolescent girls and young women in ten high-prevalence African countries: a systematic review and meta-analysis. Lancet Glob. Health 7, e1521\u2013e1540 (2019).","journal-title":"Lancet Glob. Health"},{"key":"1353_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1086\/428404","volume":"191","author":"NM Flynn","year":"2005","unstructured":"Flynn, N. M. et al. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J. Infect. Dis. 191, 654\u2013665 (2005).","journal-title":"J. Infect. Dis."},{"key":"1353_CR4","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1086\/508748","volume":"194","author":"P Pitisuttithum","year":"2006","unstructured":"Pitisuttithum, P. et al. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J. Infect. Dis. 194, 1661\u20131671 (2006).","journal-title":"J. Infect. Dis."},{"key":"1353_CR5","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","volume":"372","author":"SP Buchbinder","year":"2008","unstructured":"Buchbinder, S. P. et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372, 1881\u20131893 (2008).","journal-title":"Lancet"},{"key":"1353_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","volume":"11","author":"GE Gray","year":"2011","unstructured":"Gray, G. E. et al. Safety and efficacy of the HVTN 503\/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect. Dis. 11, 507\u2013515 (2011).","journal-title":"Lancet Infect. Dis."},{"key":"1353_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1473-3099(14)70020-9","volume":"14","author":"GE Gray","year":"2014","unstructured":"Gray, G. E. et al. Recombinant adenovirus type 5 HIV gag\/pol\/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503\/Phambili study. Lancet Infect. Dis. 14, 388\u2013396 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"1353_CR8","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","volume":"361","author":"S Rerks-Ngarm","year":"2009","unstructured":"Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209\u20132220 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1353_CR9","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","volume":"369","author":"SM Hammer","year":"2013","unstructured":"Hammer, S. M. et al. Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine. N. Engl. J. Med. 369, 2083\u20132092 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1353_CR10","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2031499","volume":"384","author":"GE Gray","year":"2021","unstructured":"Gray, G. E. et al. Vaccine efficacy of ALVAC-HIV and bivalent subtype C gp120-MF59 in adults. N. Engl. J. Med. 384, 1089\u20131100 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1353_CR11","unstructured":"A study to assess the efficacy of a heterologous prime\/boost vaccine regimen of Ad26.Mos4.HIV and aluminum phosphate-adjuvanted clade C gp140 in preventing human immunodeficiency virus (HIV)-1 infection in women in Sub-Saharan Africa. NIH https:\/\/ClinicalTrials.gov\/show\/NCT03060629 (2022)."},{"key":"1353_CR12","unstructured":"A study of heterologous vaccine regimen of adenovirus serotype 26 Mosaic4 human immunodeficiency virus (Ad26.Mos4.HIV), adjuvanted clade C gp140 and Mosaic gp140 to prevent HIV-1 infection among cis-gender men and transgender individuals who have sex with cis-gender men and\/or transgender individuals. NIH https:\/\/ClinicalTrials.gov\/show\/NCT03964415 (2023)."},{"key":"1353_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nm.4105","volume":"22","author":"M Vaccari","year":"2016","unstructured":"Vaccari, M. et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat. Med. 22, 762\u2013770 (2016).","journal-title":"Nat. Med."},{"key":"1353_CR14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41591-018-0025-7","volume":"24","author":"M Vaccari","year":"2018","unstructured":"Vaccari, M. et al. HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition. Nat. Med. 24, 847\u2013856 (2018).","journal-title":"Nat. Med."},{"key":"1353_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36109-8","volume":"14","author":"M Bissa","year":"2023","unstructured":"Bissa, M. et al. HIV vaccine candidate efficacy in female macaques mediated by cAMP-dependent efferocytosis and V2-specific ADCC. Nat. Commun. 14, 575 (2023).","journal-title":"Nat. Commun."},{"key":"1353_CR16","doi-asserted-by":"publisher","first-page":"102047","DOI":"10.1016\/j.isci.2021.102047","volume":"24","author":"I Silva de Castro","year":"2021","unstructured":"Silva de Castro, I. et al. Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates. iScience 24, 102047 (2021).","journal-title":"iScience"},{"key":"1353_CR17","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","volume":"366","author":"BF Haynes","year":"2012","unstructured":"Haynes, B. F. et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366, 1275\u20131286 (2012).","journal-title":"N. Engl. J. Med."},{"key":"1353_CR18","doi-asserted-by":"publisher","first-page":"32566","DOI":"10.1073\/pnas.2011501117","volume":"117","author":"LR Goes","year":"2020","unstructured":"Goes, L. R. et al. The V2 loop of HIV gp120 delivers costimulatory signals to CD4+ T cells through Integrin alpha4beta7 and promotes cellular activation and infection. Proc. Natl Acad. Sci. USA 117, 32566\u201332573 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1353_CR19","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.3389\/fimmu.2019.02759","volume":"10","author":"M Gschwandtner","year":"2019","unstructured":"Gschwandtner, M., Derler, R. & Midwood, K. S. More than just attractive: how CCL2 influences myeloid cell behavior beyond chemotaxis. Front. Immunol. 10, 2759 (2019).","journal-title":"Front. Immunol."},{"key":"1353_CR20","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/s41590-021-01026-9","volume":"22","author":"JA Tomalka","year":"2021","unstructured":"Tomalka, J. A. et al. The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination. Nat. Immunol. 22, 1294\u20131305 (2021).","journal-title":"Nat. Immunol."},{"key":"1353_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/cells9010128","volume":"9","author":"GL Negreiros-Lima","year":"2020","unstructured":"Negreiros-Lima, G. L. et al. Cyclic AMP regulates key features of macrophages via PKA: recruitment, reprogramming and efferocytosis. Cells 9, 128 (2020).","journal-title":"Cells"},{"key":"1353_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2020","unstructured":"Doran, A. C., Yurdagul, A. Jr. & Tabas, I. Efferocytosis in health and disease. Nat. Rev. Immunol. 20, 254\u2013267 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1353_CR23","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.4049\/jimmunol.1900572","volume":"203","author":"MA Rahman","year":"2019","unstructured":"Rahman, M. A. et al. Differential effect of mucosal NKp44+ innate lymphoid cells and deltagamma cells on simian immunodeficiency virus infection outcome in rhesus macaques. J. Immunol. 203, 2459\u20132471 (2019).","journal-title":"J. Immunol."},{"key":"1353_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1054-3589(07)56008-4","volume":"56","author":"JA Turpin","year":"2008","unstructured":"Turpin, J. A., Schito, M. L., Jenkins, L. M., Inman, J. K. & Appella, E. Topical microbicides: a promising approach for controlling the AIDS pandemic via retroviral zinc finger inhibitors. Adv. Pharm. 56, 229\u2013256 (2008).","journal-title":"Adv. Pharm."},{"key":"1353_CR25","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1021\/jm0492195","volume":"48","author":"LM Jenkins","year":"2005","unstructured":"Jenkins, L. M. et al. Studies on the mechanism of inactivation of the HIV-1 nucleocapsid protein NCp7 with 2-mercaptobenzamide thioesters. J. Med. Chem. 48, 2847\u20132858 (2005).","journal-title":"J. Med. Chem."},{"key":"1353_CR26","doi-asserted-by":"publisher","first-page":"6180","DOI":"10.1128\/jvi.70.9.6180-6189.1996","volume":"70","author":"JA Turpin","year":"1996","unstructured":"Turpin, J. A. et al. Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles. J. Virol. 70, 6180\u20136189 (1996).","journal-title":"J. Virol."},{"key":"1353_CR27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nchembio.456","volume":"6","author":"LM Miller Jenkins","year":"2010","unstructured":"Miller Jenkins, L. M. et al. Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer. Nat. Chem. Biol. 6, 887\u2013889 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"1353_CR28","doi-asserted-by":"publisher","first-page":"9175","DOI":"10.1128\/JVI.00820-09","volume":"83","author":"GS Wallace","year":"2009","unstructured":"Wallace, G. S. et al. Human immunodeficiency virus type 1 nucleocapsid inhibitors impede trans infection in cellular and explant models and protect nonhuman primates from infection. J. Virol. 83, 9175\u20139182 (2009).","journal-title":"J. Virol."},{"key":"1353_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/088922203762688595","volume":"19","author":"ML Schito","year":"2003","unstructured":"Schito, M. L. et al. In vivo antiviral activity of novel human immunodeficiency virus type 1 nucleocapsid p7 zinc finger inhibitors in a transgenic murine model. AIDS Res. Hum. Retroviruses 19, 91\u2013101 (2003).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"1353_CR30","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1097\/QAD.0b013e32834a1d94","volume":"25","author":"C Cheng-Mayer","year":"2011","unstructured":"Cheng-Mayer, C. et al. Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide. AIDS 25, 1833\u20131841 (2011).","journal-title":"AIDS"},{"key":"1353_CR31","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.4049\/jimmunol.2000165","volume":"204","author":"S Helmold Hait","year":"2020","unstructured":"Helmold Hait, S. et al. An SAMT-247 microbicide provides potent protection against intravaginal simian immunodeficiency virus infection of rhesus macaques, whereas an added vaccine component elicits mixed outcomes. J. Immunol. 204, 3315\u20133328 (2020).","journal-title":"J. Immunol."},{"key":"1353_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-cellbio-111315-125315","volume":"33","author":"PM Henson","year":"2017","unstructured":"Henson, P. M. Cell removal: efferocytosis. Annu. Rev. Cell Dev. Biol. 33, 127\u2013144 (2017).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"1353_CR33","doi-asserted-by":"publisher","first-page":"20877","DOI":"10.1073\/pnas.0911796106","volume":"106","author":"C Cicala","year":"2009","unstructured":"Cicala, C. et al. The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc. Natl Acad. Sci. USA 106, 20877\u201320882 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1353_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1600-0684.2009.00372.x","volume":"38","author":"M Kader","year":"2009","unstructured":"Kader, M., Bixler, S., Roederer, M., Veazey, R. & Mattapallil, J. J. CD4 T cell subsets in the mucosa are CD28+Ki-67\u2212HLA\u2212DR\u2212CD69+ but show differential infection based on alpha4beta7 receptor expression during acute SIV infection. J. Med. Primatol. 38, 24\u201331 (2009).","journal-title":"J. Med. Primatol."},{"key":"1353_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1615\/CritRevImmunol.v29.i3.10","volume":"29","author":"WL Redmond","year":"2009","unstructured":"Redmond, W. L., Ruby, C. E. & Weinberg, A. D. The role of OX40-mediated co-stimulation in T-cell activation and survival. Crit. Rev. Immunol. 29, 187\u2013201 (2009).","journal-title":"Crit. Rev. Immunol."},{"key":"1353_CR36","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1084\/jem.191.4.651","volume":"191","author":"PJ Blair","year":"2000","unstructured":"Blair, P. J. et al. CD40 ligand (CD154) triggers a short-term CD4+ T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J. Exp. Med. 191, 651\u2013660 (2000).","journal-title":"J. Exp. Med."},{"key":"1353_CR37","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/eji.201646837","volume":"47","author":"D Cibrian","year":"2017","unstructured":"Cibrian, D. & Sanchez-Madrid, F. CD69: from activation marker to metabolic gatekeeper. Eur. J. Immunol. 47, 946\u2013953 (2017).","journal-title":"Eur. J. Immunol."},{"key":"1353_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jim.2010.08.007","volume":"362","author":"A Soares","year":"2010","unstructured":"Soares, A. et al. Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J. Immunol. Methods 362, 43\u201350 (2010).","journal-title":"J. Immunol. Methods"},{"key":"1353_CR39","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","volume":"25","author":"RV Parry","year":"2005","unstructured":"Parry, R. V. et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25, 9543\u20139553 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"1353_CR40","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00262-006-0272-1","volume":"56","author":"C Blank","year":"2007","unstructured":"Blank, C. & Mackensen, A. Contribution of the PD-L1\/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion. Cancer Immunol. Immunother. 56, 739\u2013745 (2007).","journal-title":"Cancer Immunol. Immunother."},{"key":"1353_CR41","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.4049\/jimmunol.1402176","volume":"194","author":"X Tian","year":"2015","unstructured":"Tian, X. et al. The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects. J. Immunol. 194, 3873\u20133882 (2015).","journal-title":"J. Immunol."},{"key":"1353_CR42","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/advances\/nmz013","volume":"10","author":"SA Read","year":"2019","unstructured":"Read, S. A., Obeid, S., Ahlenstiel, C. & Ahlenstiel, G. The role of zinc in antiviral immunity. Adv. Nutr. 10, 696\u2013710 (2019).","journal-title":"Adv. Nutr."},{"key":"1353_CR43","first-page":"537","volume":"61","author":"AS Prasad","year":"1963","unstructured":"Prasad, A. S., Miale, A. Jr., Farid, Z., Sandstead, H. H. & Schulert, A. R. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypognadism. J. Lab. Clin. Med. 61, 537\u2013549 (1963).","journal-title":"J. Lab. Clin. Med."},{"key":"1353_CR44","first-page":"263","volume":"64","author":"K Tone","year":"1991","unstructured":"Tone, K., Suzuki, T. & Todoroki, T. Influence of zinc deficiency on phagocytosis in mice. Kitasato Arch. Exp. Med 64, 263\u2013269 (1991).","journal-title":"Kitasato Arch. Exp. Med"},{"key":"1353_CR45","first-page":"114","volume":"68","author":"JJ Wirth","year":"1989","unstructured":"Wirth, J. J., Fraker, P. J. & Kierszenbaum, F. Zinc requirement for macrophage function: effect of zinc deficiency on uptake and killing of a protozoan parasite. Immunology 68, 114\u2013119 (1989).","journal-title":"Immunology"},{"key":"1353_CR46","doi-asserted-by":"publisher","first-page":"e110056","DOI":"10.1371\/journal.pone.0110056","volume":"9","author":"R Hamon","year":"2014","unstructured":"Hamon, R. et al. Zinc and zinc transporters in macrophages and their roles in efferocytosis in COPD. PLoS ONE 9, e110056 (2014).","journal-title":"PLoS ONE"},{"key":"1353_CR47","doi-asserted-by":"publisher","first-page":"6491","DOI":"10.4049\/jimmunol.181.9.6491","volume":"181","author":"H Haase","year":"2008","unstructured":"Haase, H. et al. Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes. J. Immunol. 181, 6491\u20136502 (2008).","journal-title":"J. Immunol."},{"key":"1353_CR48","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nchembio.320","volume":"6","author":"JL Jenkins","year":"2010","unstructured":"Jenkins, J. L. & Urban, L. Phenotypic screening: fishing for neuroactive compounds. Nat. Chem. Biol. 6, 172\u2013173 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"1353_CR49","doi-asserted-by":"publisher","first-page":"8327","DOI":"10.1021\/jacs.9b02743","volume":"141","author":"LM Miller Jenkins","year":"2019","unstructured":"Miller Jenkins, L. M. et al. Inhibition of HIV maturation via selective unfolding and cross-linking of Gag polyprotein by a mercaptobenzamide acetylator. J. Am. Chem. Soc. 141, 8327\u20138338 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"1353_CR50","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","volume":"172","author":"SA Lambert","year":"2018","unstructured":"Lambert, S. A. et al. The human transcription factors. Cell 172, 650\u2013665 (2018).","journal-title":"Cell"},{"key":"1353_CR51","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jinorgbio.2011.11.020","volume":"111","author":"C Andreini","year":"2012","unstructured":"Andreini, C. & Bertini, I. A bioinformatics view of zinc enzymes. J. Inorg. Biochem. 111, 150\u2013156 (2012).","journal-title":"J. Inorg. Biochem."},{"key":"1353_CR52","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/nu9060624","volume":"9","author":"NZ Gammoh","year":"2017","unstructured":"Gammoh, N. Z. & Rink, L. Zinc in infection and inflammation. Nutrients 9, 624 (2017).","journal-title":"Nutrients"},{"key":"1353_CR53","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/nu9121286","volume":"9","author":"I Wessels","year":"2017","unstructured":"Wessels, I., Maywald, M. & Rink, L. Zinc as a gatekeeper of immune function. Nutrients 9, 1286 (2017).","journal-title":"Nutrients"},{"key":"1353_CR54","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3945\/jn.109.111492","volume":"140","author":"A Sheikh","year":"2010","unstructured":"Sheikh, A. et al. Zinc influences innate immune responses in children with enterotoxigenic Escherichia coli-induced diarrhea. J. Nutr. 140, 1049\u20131056 (2010).","journal-title":"J. Nutr."},{"key":"1353_CR55","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fmicb.2018.00502","volume":"9","author":"L Kjellerup","year":"2018","unstructured":"Kjellerup, L., Winther, A. L., Wilson, D. & Fuglsang, A. T. Cyclic AMP pathway activation and extracellular zinc induce rapid intracellular zinc mobilization in Candida albicans. Front. Microbiol. 9, 502 (2018).","journal-title":"Front. Microbiol."},{"key":"1353_CR56","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/imm.13452","volume":"165","author":"T Kido","year":"2022","unstructured":"Kido, T., Suka, M. & Yanagisawa, H. Effectiveness of interleukin-4 administration or zinc supplementation in improving zinc deficiency-associated thymic atrophy and fatty degeneration and in normalizing T cell maturation process. Immunology 165, 445\u2013459 (2022).","journal-title":"Immunology"},{"key":"1353_CR57","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jim.2016.03.002","volume":"433","author":"C Orlandi","year":"2016","unstructured":"Orlandi, C., Flinko, R. & Lewis, G. K. A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies. J. Immunol. Methods 433, 51\u201358 (2016).","journal-title":"J. Immunol. Methods"},{"key":"1353_CR58","doi-asserted-by":"publisher","first-page":"e0186998","DOI":"10.1371\/journal.pone.0186998","volume":"12","author":"S Reiss","year":"2017","unstructured":"Reiss, S. et al. Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells. PLoS ONE 12, e0186998 (2017).","journal-title":"PLoS ONE"}],"updated-by":[{"DOI":"10.1038\/s41564-023-01412-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000}}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-023-01353-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-023-01353-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-023-01353-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T07:08:01Z","timestamp":1684825681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-023-01353-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["1353"],"URL":"https:\/\/doi.org\/10.1038\/s41564-023-01353-7","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41564-023-01412-z","asserted-by":"object"}]},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"assertion":[{"value":"2 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41564-023-01412-z","URL":"https:\/\/doi.org\/10.1038\/s41564-023-01412-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests. The US government filed Patent No. 63\/228,707: HIV vaccination and SAMT-247 microbicide to prevent HIV infection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}